Today is Wednesday, Jul. 15, 2020

Department of Internal Medicine

Nephrology and Hypertension

Photo of  Kotagal Kant, MD

Kotagal Kant, MD

Professor of Medicine

Clinical Interest

Nephrology

Specialties

Internal Medicine
Nephrology

Education/Credentials
  • Medical Degree: All India Institute of Medical Sciences
  • Residency: Michael Reese Hospital and Medical Center
  • Fellowship: University of Cincinnati Medical Center
Board Certifications & Licenses
  • American Board of Internal Medicine 06/19/1974
  • American Board of Internal Medicine (Nephrology) 10/19/1976
Contact Information
  • Medical Sciences Building
  • Room G163A
  • 231 Albert Sabin Way
  • Cincinnati, Ohio 45267
  • Office 513-558-5471
  • Fax 513-558-4309
  • Email shashi.kant@uc.edu

Peer Reviewed Publications

Kant, K Shashi; Gonzalez, Alejandro R; Hariachar, Srinivas; Bernardo, Marializa; Duggal, Ajay; Engstrand, Sara; Hunter, John; Plone, Melissa; Hertel, Joachim 2011. Converting to Doxercalciferol Capsules From Intravenous Paricalcitol or Doxercalciferol Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, ,

Nicolaou, Stella A; Neumeier, Lisa; Takimoto, Koichi; Lee, Susan Molleran; Duncan, Heather J; Kant, Shashi K; Mongey, Anne Barbara; Filipovich, Alexandra H; Conforti, Laura 2010. Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosus. Cell calcium, 47 1, 19-28

Duncan, Heather J; Pittman, Susan; Govil, Amit; Sorn, Lisa; Bissler, Gloria; Schultz, Tersea; Faith, J; Kant, Shashi; Roy-Chaudhury, Prabir 2007. Alternative medicine use in dialysis patients: potential for good and bad! Nephron. Clinical practice, 105 3, c108-13

Nicolaou, Stella A; Szigligeti, Peter; Neumeier, Lisa; Lee, Susan Molleran; Duncan, Heather J; Kant, Shashi K; Mongey, Anne Barbara; Filipovich, Alexandra H; Conforti, Laura 2007. Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus. Journal of immunology (Baltimore, Md. : 1950), 179 1, 346-56

El-Khatib, Mahmoud; Duncan, Heather J; Kant, K Shashi 2006. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients. Nephrology (Carlton, Vic.), 11 5, 400-4

Kant, K Shashi; Cook, E Francis; Duncan, Heather; Freyberg, Ron 2002. Parathyroid hormone suppression by intravenous calcitriol: role of phosphate, calcium, race and diabetes. The American journal of the medical sciences, 323 4, 210-5

Bleyer AJ, Burke SK, Dillon M, Garrett B, Kant KS, Lynch D, Rodman SN, Schoenfeld P, Teitelbaum I, Zeig S, Slatopolsky E 1999. A comparison of the calcium free-phosphate binder sevelamer hydrocholoride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients Am J Kidney Disease, 33 , 694-701

Peddi VR, Kant KS 1998. Catastrophic secondary antiphospholipid syndrome with concomitant antithrombin III deficiency J Am Soc Nephrol, 5 , 1882-1887

Kant KS 1994. Intradialytic cardiac arrhythmias: II Seminars in Dialysis, 7 , 58-60

Padilla B, Pollak VE, Pesce A, Kant KS, Gilinsky NH, Deddens JA 1994. Pancreatitis in patients with end-stage renal disease Medicine (Baltimore), 73 , 8-20

Asherson RA, Kant KS 1993. Antiphospholipid antibodies and the kidney J of Rheumat, 20 , 1267-1272

Pollak VE, Thornley-Brown D, kant KS, Pesce A, Deddens JA 1993. A case study of a recent decline in the dalysis fatality rate Contrib Nephrol, 102 , 59-72

Kant KS, Glueck HI, Coots MC, Tonne VA, Brubaker R, Penn I 1992. Protein S deficiency and skin necrosis associated with continuous ambulatory peritoneal dialysis Am J Kidney Disease, 19 , 264-271

Padilla B, Weiss M, Kant KS 1992. Henoch-Schonlein purpura in a patient with diabetic nephropathy: Case report and a review of the literature Am J Kidney Disease, 20 , 191-194

Pollak VE, Kant KS, Pesce A, Cathey M 1992. Continous quality improvement in chronic disease: Early detection of a mini-cluster of pyrogenic reactions during hemodialysis and the effect of on-line monitoring Dialysis and Transplantation, 21 , 330-339

Pollak VE, Pesce A, Kant KS 1992. Continuous quality improvement in chronic disease: a computerized medical record enables description of a severity index to evaluate outcomes in end-stage renal disease Am J Kidney Disease, 19 , 514-522

Thornley-Brown D, Galla JH, Williams PD, Kant KS, Rashkin M 1992. Lithium toxicity associated with trichobezoar Ann Intern Med, 116 , 739-740

Pollak VE, Kant KS, Hariharan S 1991. Diffuse and focal proliferative lupus nephritis: Treatment approaches and results Nephron, 59 , 177-193

Hariharan S, Pollak VE, Kant KS, Weiss MA, Wadhwa NK 1990. Diffuse proliferative lupus nephritis: long-term observations in patients treated with ancrod Clin Nephrol, 34 , 61-69

Sridhar NR, Thornley-Brown D, Kant K 1990. Peritonitis due to Aspergillus niger: diagnostic importance of peritoneal eosinophilia Perit Dial Int, 10 , 100-101

First MR, Smith RD, Weiss, MA, Schroeder TJ, Kant KS, Minda R, Stephens GW, Penn I, Alexander JW 1989. Cyclosporine-associated glomerular and arteriolar thrombosis following renal transplantation Transplant Proc, 21 , 1567-1570

Kant, KS 1989. Treatment of recurrent peritonitis Perit Dial Int, 9 , 355

Kant KS, Goetz D, Marzluff C, Motz D 1988. Relapsing peritonitis in continuous ambulatory peritoneal dialysis (CAPD): Treatment by interruption of CAPD and prolonged antibiotic therapy Perit Dial Int, 8 , 155-157

Kim S, Washwa NK, Kant KS, Pollak VE, Glas-Greenwalt P, Weiss MA, Hong CG 1988. Fibrinolysis in glomerulonephritis treated with ancrod: Renal functional, immunologic and histopathologic effects Q J Med, 69 , 879-905

Pollak VE, Charoenpanich R, Robson M, Kant KS 1988. Dialyzer membranes: syndromes associated with first use and effects of multiple use Kindey Int, Suppl 24 , S49-S52

Charoenpanich R, Pollak VE, Kant KS, Robson MD, Cathey M, 1987. Effect of first and subsequent use of hemodialyzers on patient well-being: The rise and fall of a syndrome associated with new dialyzer use Artif Organs, 11 , 123-127

Pollak VE, Kant KS 1987. Autoimmune glomerulonephritis: An approach to certain pathogenetic factors and their relation to treatment Clin Aspect of Autoimmunity, 1 , 2-11

Glas-Greenwalt P, Hall JM, Panke TW, Kant KS, Allen CM, Pollak VE 1986. Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen inhibitor, and protein C in thrombotic thrombocytopenic purpura J Lab Clin Med, 108 , 415-422

Pollak VE, Kant KS, Parnell SL, Levin NW 1986. Repeated use of dialyzers is safe: Long-term observations on morbidity and mortality in patients with end-stage renal disease Nephron, 42 , 217-223

Robson MD, Charoenpanich R, Kant KS, Peterson DW, Flynn J, Cathey M, Pollak VE 1986. Effect of first ans subsequent use of hemodialyzers on patient well-being: Analysis of the incidence of symptoms and events and description of a syndrome associate with new dialyzer use Am J Nephrol, 6 , 101-106

Du X-H, Glas-Greenwalt P, Kant KS, Allen CM, Hayes S, Pollak VE 1985. Nephrotic syndrome with renal vein thrombosis: Pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin) Clin Nephrol, 24 , 186-191

Garcia G, Deddens JA, D-Achiardi-Rey R, First MR, Samuels SJ, Kant KS, Pollak VE 1985. Results of treatment in patients with end-stage renal disease: A multivariate analysis of risk factors and survival in 341 successive patients Am J Kidney Disease, 5 , 10-18

Glas-Greenwalt P, Kant KS, Dosekun A, Frazier J, Allen C, Pollak VE 1985. Ancros: Normalization of fibrinolyti enzyme abnormalities in patients with systemic lupus erythematous and lupus nephritis J Lab Clin Med, 105 , 99-107

Glueck HI, Kant KS, Weiss MA, :Pollak VE, Miller MA, Coots M 1985. Thrombosis in systemic lupus erythematosus: Relation to the presence of circulating anicoagulants Arch Intern Med, 145 , 1389-1395

Kant KS, Pollak VE, Dosekun A, Glas-Greenwalt P, Weiss MA, Glueck HI 1985. Lupus nephritis with thrombosis and abnormal fibrinolysis: Effect of ancrod J Lab Clin Med, 105 , 77-88

Dosekun AK, Pollak VE, Glas-Greenwalt P, Kant KS, Penovich P, Lebron-Berges A, Weiss MA, Levinson JE 1984. Ancrod in systemic lupus erythematosus and with thrombosis: clinical and fibrinolysis effects Arch Intern Med, 44 , 37-42

Glas-Greenwalt P, Kant KS, Allen C, Pollak VE 1984. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus J Lab Clin Med, 104 , 962-976

Dosekun AK, First MR, Chandran PK, Kant KS, Glas-Greenwalt P, Weiss MA, Alexander JW, Pollak VE 1982. Successful treatment by defibrination with ancrod in a patient with hyperacute renal allograft failure and a deficiency of plasma prostacyclin stimulating factor Clin Nephrol, 18 , 101-105

Grant KD, Kant KS, Pollak VE, Weiss MA, Hess EV 1982. Thrombosis in the lupus kidney Arthritis Rheum, 25 , 117

Kant KS, Dosekun AK, Chandran KG, Glas-Greenwalt P, Weiss MA, Pollak VE 1982. Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: Ino-vivo and in-vitro observations Thromb Res, 27 , 641-658

First MR, Munda R, Kant KS, Fidler JP, Alexander JW 1981. Steroid withdrawal following HLA-identical related donor transplantation Transplant Proc, 13 , 319-322

Kant KS, Pollak VE, Cathey M, Goetz D, Berlin R 1981. Multiple use of dialyzers: Safety and efficacy Kindey Int, 19 , 728-138

Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller AN, Hess EV 1981. Glomerular thrombosis in systemic lupus erythematosus: Prevalence and significance Medicine (Baltimore), 60 , 71-86

Ooi BS, Weiss MA, Kant KS, Hong CF, Pollak VE, Andriole VT 1981. Antibody to Tamm-Horsfall protein after acute tubular necrosis Am J Nephrol, 1 , 48-51

Pollak VE, Kant KS 1981. Nephritis in systemic lupus erythematosus (natural history, treatment and pathogenesis) Ric Clin Lab, 11 , 1-10

Kant KS, Pollak VE, Goetz D, Cathey M 1980. Dialyzer reuse: a long-term study of safety and efficacy at one center Proc Clin Dial Transplant Forum, 10 , 35-38

Pesce AJ, Clyne DH, Pollak VE, Kant, KS 1980. Renal tubular interactions of proteins Clin Biochem, 13 , 209-215

Clyne DH, Kant KS, Pesce AJ, Pollak VE 1979. Nephrotoxicity of low molecular weight serum proteins: Physiochemical interactions between myoglobin, hemoglobin, Bence-Jones proteins and Tamm-Horsfall mucoprotein Curr Probl Clin Biochem, 299-308,

Pesce AJ, Kant KS, Hanenson IB, Pollak VE 1978. Autoimmunity and systemic lupus erythematosus Clinical Immunochemistry, ,

Pesce AJ, Kant KS, Ooi BS, Pollak VE 1978. The application of enzyme immunoassay in the diagnosis of autoimmune diseases Scand J Immun, 8 (suppl 7) , 91-96

Ooi BS, Kant KS, Hanenson IB, Pesce AJ, Pollak VE 1977. Lymphocytotoxins in epileptic patients receiving phenytoin Clin Exp Immunol, 30 , 56-61

Kant, Shashi . Choices of ecosystem capital without discounting and prices. Environmental monitoring and assessment, 86 1-2, 105-27

Kant, Shashi; Haldar, Partha . Is NDM-1 actually being imported to UK from India? Indian journal of public health, 54 3, 151-4

Lal, Vivek; Kant, Shashi; Dewan, Richa; Rai, Sanjay K; Biswas, Ashutosh . A two-site hospital-based study on factors associated with nonadherence to highly active antiretroviral therapy. Indian journal of public health, 54 4, 179-83

Malhotra, Sumit; Kant, Shashi . Adverse female-to-male sex ratio at birth in India: a cause for concern. The National medical journal of India, 19 3, 152-4

Pandey, Arvind; Thomas, M; Reddy, D C S; Kant, Shashi; Bhattacharya, M . Process of estimating the number of people living with HIV in India. Indian journal of public health, 51 1, 7-13

Abstract Publications

Kant KS, El-Khatib MT, Duncan HJ 2009. Use of Antibiotic-Locking Solutions to Decrease Hemodialysis Catheter Related Bacteremia: Long-Term Impact on CRB Rates and Bacterial Resistance Amer Soc Neph, ,

Kant KS, Duncan HJ, Tallarico BJ, McKinney RA, Diadato CL 2008. Does the buttonhole technique of AV fistula cannulation increase risk of bacteremia? Amer Soc Neph, 19 , 262A

Nicolaou S, Szigletti P, Duncan H, Neumeier L, Lee S, Kant K, Filipovich A, Conforti L 2006. Altered dynamics of Kv 1.3 channel compartmentalization in the immunological synapse in SLE J Clinical Immunology, 119 , 568

Du Xo-H, Glas-Greenwalt P, Kant KS, Pollak VE 1984. Nephrotic syndrome with renal vein thrombosis: Pathogenetic importance of a plasmin inhibitor Clin Res, 32 , 445A

Glas-Greenwalt P, Olinger CP, Kant KS, Healy L, Pollak VE 1984. Severe abnormalities of the fibrin-clearing in multiple sclerosis Clin Res, 32 , 496A

Kant KS, Glas-Greenwalt P, Sexton J, Pollak VE 1984. Endothelial cell plasminogen activator production: Effect of mediators of inflammation Clin Res, 32 , 349A

Glas-Greenwalt P, Kant KS, Allen C, Dosekun AK, Pollak VE 1982. Impaired fibrinolysis in systemic lupus erythematosus and thrombotic thrombocytopenic purpura Clin Res, 30 , 502A

Kant KS, Pesce AJ, Clyne DH, Pollak VE 1977. Coprecipitation of Tamm-Horsfall protein with myoglobin hemoglobin and Bence-Jones proteins Clin Res, 25 , 594A